Evercore ISI analyst Elizabeth Anderson made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1. The firm added Charles River (CRL) to its “Tactical Outperform” list and keeps an Outperform rating and $200 price target on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Charles River: Portfolio Reshaping Improves Margins but Lowers Growth, Supporting Hold Rating
- Sharpened Focus and Strategic Divestitures Underpin Buy Rating on Charles River Amid Valuation Discount
- Charles River price target raised to $175 from $170 at UBS
- Charles River Labs divests units to sharpen profitability focus
- Iqvia to acquire certain discovery services assets from Charles River